BBNX R&D to Revenue

Beta Bionics Inc · R&D to Revenue

BBNX logo

BBNX R&D to Revenue

Latest reported34.70%
BBNX FY R&D/Revenue (17557.54% → 34.70%)
High-resolution chart · PNG

BBNX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Beta Bionics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
34.7019%
40.2064%
149.5873%
17,557.5419%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.